At Novartis, we are dedicated to redefining the standard of care for people living with diverse types of cancer. Neuroendocrine tumors (NETs) are types of cancer that can often be misdiagnosed due to the vague nature of their symptoms that can be similar to common conditions such as: anxiety, menopause, irritable bowel syndrome, asthma or diabetes. We are supporting the global NET patient community to raise awareness about different types of NETs and share more information about transforming can

#NeuroendocrineTumors (#NETs) are rare cancers that can develop in different organs and tissues, but the majority (more than 60%) originate in the digestive system. When they do, they are called gastroenteropancreatic neuroendocrine tumors, or GEP-NETs for short. The journey to diagnosis is often long and takes a toll on patients’ overall wellbeing. On average, it can take over four years from first onset of symptoms to a final diagnosis, after an extensive medical journey, including many examin